1-4 of 4
Patrick N. Harter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2161: Identifying GDF-15 as potential novel immunotherapeutic target linked to immune cell exclusion in tumors and resistance to anti-PD-1 treatment

Free
Jorg Wischhusen, Kilian Wistuba-Hamprecht, Patrick N. Harter, Phil Cheng, Alexander Martens, Falk Gogolla, Yumi Nonomura, Paula Romer, Sven D. Koch, Markus Haake, Christine Schuberth-Wagner, Manfred Rudiger, Eugen Leo, Michael Mittelbronn, Mitchell P. Levesque, Hubert Hackl, Reinhard Dummer, Benjamin Weide
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 2161.
https://doi.org/10.1158/1538-7445.AM2020-2161
Published: 15 August 2020
View articletitled, Abstract 2161: Identifying GDF-15 as potential novel immunotherapeutic target linked to immune cell exclusion in tumors and resistance to anti-PD-1 treatment
Journal Articles

Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma

Available to Purchase
Giorgia Mastrella, Mengzhuo Hou, Min Li, Veit M. Stoecklein, Nina Zdouc, Marie N.M. Volmar, Hrvoje Miletic, Sören Reinhard, Christel C. Herold-Mende, Susanne Kleber, Katharina Eisenhut, Gaetano Gargiulo, Michael Synowitz, Angelo L. Vescovi, Patrick N. Harter, Josef M. Penninger, Ernst Wagner, Michel Mittelbronn, Rolf Bjerkvig, Dolores Hambardzumyan, Ulrich Schüller, Jörg-Christian Tonn, Josefine Radke, Rainer Glass, Roland E. Kälin
Journal: Cancer Research
Cancer Res (2019) 79 (9): 2298–2313.
https://doi.org/10.1158/0008-5472.CAN-18-0881
Published: 01 May 2019
View articletitled, Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
Open the PDF for Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Tumorigenic and Antiproliferative Properties of the TALE-Transcription Factors MEIS2D and MEIS2A in Neuroblastoma

Available to Purchase
Anja Groß, Catrine Schulz, Jasmine Kolb, Jan Koster, Sibylle Wehner, Sebastian Czaplinski, Abdulghani Khilan, Hermann Rohrer, Patrick N. Harter, Thomas Klingebiel, Julian D. Langer, Dirk Geerts, Dorothea Schulte
Journal: Cancer Research
Cancer Res (2018) 78 (8): 1935–1947.
https://doi.org/10.1158/0008-5472.CAN-17-1860
Published: 12 April 2018
View articletitled, Tumorigenic and Antiproliferative Properties of the TALE-Transcription Factors MEIS2D and MEIS2A in Neuroblastoma
Open the PDF for Tumorigenic and Antiproliferative Properties of the TALE-Transcription Factors MEIS2D and MEIS2A in Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Abstract 3797: Regulation and function of the mucin-like glycoprotein podoplanin in glioma.

Free
Heike Peterziel, Julia Müller, Danner Andreas, Sebastian Barbus, Haikun Liu, Philipp Pfenning, Patrick N. Harter, Michel Mittelbronn, Wolfgang Wick, Günther Schuetz, Bernhard Radlwimmer, Peter Lichter, Jochen Hess, Peter Angel
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3797.
https://doi.org/10.1158/1538-7445.AM2013-3797
Published: 15 April 2013
View articletitled, Abstract 3797: Regulation and function of the mucin-like glycoprotein podoplanin in glioma.